Cite

HARVARD Citation

    Ma, C. et al. (n.d.). Ustekinumab Is Effective for the Induction and Maintenance of Response in Crohn's Disease: A Multi‐center Cohort Study. American journal of gastroenterology. p. . [Online]. 
  
Back to record